Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors.

por Linda E Flinterman, Astrid van Hylckama Vlieg, Suzanne C Cannegieter, Frits R Rosendaal
Publicado 2012

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis

por Eleonora Camilleri, Nienke van Rein, Felix J. M. van der Meer, Melchior C. Nierman, Willem M. Lijfering, Suzanne C. Cannegieter, The Dutch COVID & Thrombosis Coalition
Publicado 2021

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

por Gilda Denise Zielinski, Nienke vanRein, Martina Teichert, Frederikus A. Klok, Frits R. Rosendaal, Felix J. M. van derMeer, Menno V. Huisman, Suzanne C. Cannegieter, Willem M. Lijfering
Publicado 2020

Association of smoking and cancer with the risk of venous thromboembolism: the Scandinavian Thrombosis and Cancer cohort

por Benedikte Paulsen, Olga V. Gran, Marianne T. Severinsen, Jens Hammerstrøm, Søren R. Kristensen, Suzanne C. Cannegieter, Hanne Skille, Anne Tjønneland, Frits R. Rosendaal, Kim Overvad, Inger Anne Næss, John-Bjarne Hansen, Sigrid K. Brækkan
Publicado 2021

Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease.

por Judith Kooiman, Nienke van Rein, Bas Spaans, Koen A J van Beers, Jonna R Bank, Wilke R van de Peppel, Antonio Iglesias del Sol, Suzanne C Cannegieter, Ton J Rabelink, Gregory Y H Lip, Frederikus A Klok, Menno V Huisman
Publicado 2014